Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Connect Biopharma Holdings Ltd
Pre-Tax Income
Connect Biopharma Holdings Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
|
Pre-Tax Income
-¥59.4m
|
CAGR 3-Years
58%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Pre-Tax Income
-¥6.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Pre-Tax Income
-¥1.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Pre-Tax Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Pre-Tax Income
¥8.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
35%
|
CAGR 10-Years
50%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Pre-Tax Income
¥1.5B
|
CAGR 3-Years
62%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
See Also
What is Connect Biopharma Holdings Ltd's Pre-Tax Income?
Pre-Tax Income
-59.4m
CNY
Based on the financial report for Dec 31, 2023, Connect Biopharma Holdings Ltd's Pre-Tax Income amounts to -59.4m CNY.
What is Connect Biopharma Holdings Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
9%
Over the last year, the Pre-Tax Income growth was 93%. The average annual Pre-Tax Income growth rates for Connect Biopharma Holdings Ltd have been 58% over the past three years , 9% over the past five years .